IBEX Ltd: Robert Thomas Dechant proposes $250K sale
The notice also lists a prior 5,000-share sale on September 25, 2026, for gross proceeds of $225,095.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IBEX Ltd officer and director Robert Thomas Dechant reported a proposed sale of 5,000 common shares, with an approximate sale date of November 9, 2026. The proposed sale has an aggregate market value of $250,031 and is pursuant to a Rule 10b5-1 plan established November 18, 2025. Dechant also reported a sale of 5,000 shares on September 25, 2026, for gross proceeds of $225,095. The shares covered by the proposed sale were acquired from the issuer through an RSA vest on December 28, 2018.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.